Does somatostatin or gastric inhibitory peptide receptor expression correlate with tumor grade and stage in gut neuroendocrine tumors?

@article{Krner2015DoesSO,
  title={Does somatostatin or gastric inhibitory peptide receptor expression correlate with tumor grade and stage in gut neuroendocrine tumors?},
  author={Meike U K{\"o}rner and Beatrice Waser and Jean Claude Reubi},
  journal={Neuroendocrinology},
  year={2015},
  volume={101 1},
  pages={
          45-57
        }
}
BACKGROUND/AIMS Important characteristics of neuroendocrine neoplasms (NEN) for prognosis and therapeutic decisions are the MIB-1 proliferative index (tumor grade) and tumor stage. Moreover, these tumors express peptide hormone receptors like somatostatin and gastric inhibitory peptide (GIP) receptors which represent important established and potential future targets, respectively, for molecular imaging and radiotherapy. However, the interrelation between tumor proliferation, stage, and peptide… CONTINUE READING
4 Citations
37 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 37 references

gestive Neuroendocrine Tumors: an update

  • F Bosman, F Carneiro, RH Hruban
  • Neuroendocrinology
  • 2012

Similar Papers

Loading similar papers…